1.
Emerg Infect Dis
; 23(5): 867-869, 2017 05.
Article
de Anglais
| MEDLINE
| ID: mdl-28418307
RÉSUMÉ
In response to a university-based serogroup B meningococcal disease outbreak, the serogroup B meningococcal vaccine Trumenba was recommended for students, a rare instance in which a specific vaccine brand was recommended. This outbreak highlights the challenges of using molecular and immunologic data to inform real-time response.